Literature DB >> 12382403

Posterior mitral annuloplasty with a flexible linear reducer.

Hitoshi Matsumoto1, Ryuzo Sakata, Yoshifumi Iguro, Hiroshi Masuda, Tamahiro Kinjo, Gouichi Yotsumoto, Kenichi Arata, Kazuhisa Matsumoto.   

Abstract

OBJECTIVES: We evaluated posterior annuloplasty results using a flexible linear reducer, especially as a cardiac surgical procedure.
METHODS: Subjects were 24 patients consisting of 20 men and 4 women aged 7 to 79 years (mean; 61.3 years) with mitral regurgitation who underwent mitral valve reconstruction using a flexible linear reducer from May 1999 to April 2001. Mitral regurgitation was attributed to myocardial ischemia in 9 (37.5%). Isolated mitral valve repair was conducted only in 3 (12.5%) and concomitant procedures in 21 (87.5%).
RESULTS: No operative deaths occurred. One hospital death (4.2%) occurred due to cardiac failure on postoperative day 58. Four late deaths (16.7%) occurred 8 to 15 months after surgery due to heart failure, stroke, and cancer. No patients required reoperation and no perioperative complications occurred. Doppler echocardiography conducted in all patients within a month postoperatively showed excellent valve function: 11 (45.8%) had no residual regurgitation, 5 (20.8%) had trivial insufficiency, 6 (25%) had mild insufficiency, 2 (8.3%) had moderate insufficiency, and none had severe insufficiency. We observed significantly reducted enddiastolic and systolic left ventricular diameter while ejection fraction remained unchanged.
CONCLUSIONS: Posterior mitral annuloplasty using a flexible linear reducer is simple, saves time, and is useful for the small left atrium and as an additional procedure in other cardiac surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12382403     DOI: 10.1007/BF02913186

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  8 in total

1.  Cardiac valve surgery--the "French correction".

Authors:  A Carpentier
Journal:  J Thorac Cardiovasc Surg       Date:  1983-09       Impact factor: 5.209

2.  Valve repair with Carpentier techniques. The second decade.

Authors:  A Deloche; V A Jebara; J Y Relland; S Chauvaud; J N Fabiani; P Perier; G Dreyfus; S Mihaileanu; A Carpentier
Journal:  J Thorac Cardiovasc Surg       Date:  1990-06       Impact factor: 5.209

3.  Posterior annuloplasty in the surgical treatment of mitral insufficiency.

Authors:  A Pellegrini; E Quaini; T Colombo; M Lanfranchi; C Russo; E Vitali
Journal:  J Heart Valve Dis       Date:  1993-11

4.  Posterior pericardial annuloplasty: a physicological correction?

Authors:  M Salati; R Scrofani; C Santoli
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

5.  Long-term results of mitral valve reconstruction with Carpentier techniques in 148 patients with mitral insufficiency.

Authors:  A C Galloway; S B Colvin; F G Baumann; R Esposito; R Vohra; S Harty; R Freeberg; I Kronzon; F C Spencer
Journal:  Circulation       Date:  1988-09       Impact factor: 29.690

6.  Comparative morbidity of mitral valve repair versus replacement for mitral regurgitation with and without coronary artery disease.

Authors:  L H Cohn; W Kowalker; S Bhatia; V J DiSesa; M St John-Sutton; R J Shemin; J J Collins
Journal:  Ann Thorac Surg       Date:  1988-03       Impact factor: 4.330

7.  Initial experience with the Cosgrove-Edwards Annuloplasty System.

Authors:  D M Cosgrove; J M Arcidi; L Rodriguez; W J Stewart; K Powell; J D Thomas
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

8.  Mitral annuloplasty with a flexible linear reducer.

Authors:  L Camilleri; M Filaire; A Repossini; B Legault; V Eder; J P Fleury; P Bailly; C de Riberolles
Journal:  J Card Surg       Date:  1995-03       Impact factor: 1.620

  8 in total
  1 in total

1.  Feasibility of myxomatous mitral valve repair using direct leaflet and chordal radiofrequency ablation.

Authors:  Jeffrey L Williams; Yoshiya Toyoda; Takeyoshi Ota; Dmitry Gutkin; William Katz; Marco Zenati; David Schwartzman
Journal:  J Interv Cardiol       Date:  2008-10-21       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.